Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors

Clinical trial NCT05915481 · UNKNOWN

Trial details

NCT number: NCT05915481
Sponsor: Peking University Third Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Stereotactic Body Radiotherapy Immune Checkpoint Inhibitor Safety Efficacy

Start date: 2023-06-21
Primary completion: 2024-06-21
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.